Medline raises 2026 organic sales guidance to 10%-10.5%
Medline raised its 2026 organic sales guidance from 9%-10% to 10%-10.5%.
Story updates
12:37:21 PM UTC
SquawkNews
Third-quarter sales rose 10.4% to $7.9B year over year, while net income fell 1.2% to $318M. Medline raised its 2026 organic sales growth outlook to 10.0%-10.5% from 9.0%-10.0% and reaffirmed Adjusted EBITDA guidance of $3.3B-$3.4B.Material DetailsContext by AI AnalystThis is a current operating up…